Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,291 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Active, Not Recruiting

OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC

NCT04713514

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +18 more
Locations
  • UZ Leuven Leuven, Belgium
  • Centre Hospitalier de l'Ardenne Vivalia Libramont, Belgium
  • Centre Hospitalier Universitaire de Liège Liège, Belgium
  • ICO Paul Papin Angers, France
View all 40 locations
View Trial Details
Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

NCT02521844

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations
  • University of Arizona Cancer Center, 3838 N. Campbell Avenue, RM 2111, Site 203 Tucson, Arizona, United States
  • Chao Family Comprehensive Cancer Center,Stern Center for Cancer Clinical Trials and Research, 101 City Drive South, Site 209 Orange, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavilion, 12648 East 17th Avenue; MSF 700, Site 202 Aurora, Colorado, United States
  • University of Kansas Medical Center, 4350 Shawnee Mission Parkway, Suite 2310, MS 6004, Site 210 Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

NCT04205227

Conditions
Adnexal Diseases, Cancer, Digestive System Diseases, +30 more
Locations
  • Cedars Sinai-The Angeles Clinic Los Angeles, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Border Medical Oncology Albury, New South Wales, Australia
  • Blacktown Oncology Blacktown, New South Wales, Australia
View Trial Details

Related conditions